A cancer biotech’s collapse gives Neurogene a path to Wall Street

A cancer biotech’s collapse gives Neurogene a path to Wall Street

Submitted by admin on July 18, 2023 - 10:01pm
Source: 
BioPharma Dive
News Tags: 
Neurogene
gene therapy
reverse merger
Neoleukin
Headline: 
A cancer biotech’s collapse gives Neurogene a path to Wall Street
snippet: 

Gene therapy startup Neurogene has reached a deal to go public through a reverse merger with cancer drug developer Neoleukin Therapeutics, the companies announced Tuesday.

Do Not Allow Advertisers to Use My Personal information